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Human lymphocytes from dinitrochlorobenzene 
(DNCB)-sensitized human subjects primed in first cul-
ture with dinitrophenylated-antigens yield a population 
of cells which respond in an accelerated manner to the 
same or similar antigen in second culture. Using this 
"clonal priming" approach, we have demonstrated that 
such a primed population showed maximal proliferative 
response to dinitrophenylated autologous cells. These 
DNP primed clones also showed responses to some di-
nitrophenylated allogeneic leukocytes. The magnitude 
of the accelerated blastogenic response with allogeneic 
leukocytes varied in most instances in relation to the 
degree of sharing of lILA-A, B, and DRw antigens with 
the original autologous stimulator. These findings show 
that the self-specific factors recognized in conjunction 
with the dinitrophenyl antigen are closely but not invar-
iably associated with established major histocompatibil-
ity (MHC)-associated serologic typing results. While 
DNP primed clones fail to respond to unmodified autol-
ogous leukocytes, they often show significant responses 
to unmodified allogeneic leukocytes. If such accelerated 
responses to unmodified allogeneic leukocytes are not 
the result of nonspecific activation of allogeneic respond-
ing lymphocyte clones, the e findings further indicate 
that DNP modified self can resemble some alloantigens. 
We have previously shown that ultraviolet sensitive self-
specific histocompatibility-like factors are required for activa-
tion to DNP of dinitrochlorobenzene (DNCB)-sensitive human 
lymphocyte populations (1). These findings and the relative 
resistance of this stimulatory function to UV light in second 
culture indicate the factors required for lymphocyte activation 
are behaving in a manner similar to mixed leukocyte culture 
reaction (MLR) determinants. The concept of immune response 
or IR gene control has evolved from observations of differential 
immune responsiveness to various antigens in mice and guinea 
pigs [2,3]. Our studies involving in vitro priming with DNCB 
and other antigens indicate that self-specific factors are in-
volved in most if not all immune responses and lead to a 
quantitatively unique immune response to all antigens in each 
individual [4-7). These studies indicate that we are able to 
directly measure these factors relative to a sensitizing antigen 
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81: stimulation index 
with the clonal pnmmg system. We therefore refer to the 
assessment of these self-specific factors as immune response 
typing. These data indicate that the closer an allogeneic indi-
vidual is to identity (that is, with the original individual), the 
better will be the ensuing immune response. One can postulate 
that recognition of such variations from immune identity may 
have implications in immune surveillance. 
In the following study, we show that a correlation exists 
between the extent of sharing of current sero-defined human 
histocompatibility determinants and the direct assessment of 
immune response factors as measured by DNP-self primed 
lymphocytes. 
MATERIALS AND METHODS 
Preparation of First (Flask) Cultures 
Peripheral blood leukocytes were obtained by a centrifugation tech-
nique described in detail elsewhere [8]. Briefly, heparinized venous 
blood was centrifuged at 300 g for 5 min. The mononuclear leukocyte-
rich plasma was removed, adjusted to the desired cell concentration by 
addition of autologous plasma and RPMII640 (Grand Island Biological 
#187G) containing penicillin and streptomycin. Five milliliters of the 
rmal nrst (flask) cultures containing 20% autologous plasma and 0.5-1 
X 10" leukocytes/ml were incubated with DNP-aspartic acid (Lot 6590, 
Nutritional Biochemical Co.) in upright Falcon 3013 tissue culture 
flasks in a 5% C02 humidined atmosphere at 37°C (Fig 1, experiments 
4 and 5). Dinitrobenzene-sulphonic-acid (ONBSO,,) (Lot B5B, Eastman 
Kodak Co., Rochester, N. Y.) pretreatment of about half the autologous 
cells (as described under preparation of DNP-conjugated cells) instead 
of DNP-aspartic acid addition was used to initiate the first cultures in 
all other experiments. All responder leukocytes were from DNCB-
sensitized donors. Leukocytes used only as stimulators were from non-
DNCB sensitized donors. 
Preparation of Second (Clonal Primed) Cultures 
After 9 to 18 days of total incubation time, ONP-aspartic acid- and 
DNBS01-stimuiated culture flasks were gently swirled and decanted 
into conical tubes. Five milliliters of RPM! 1640 was then pipetted 
semi vigorously at the bottom of each primary culture flask to obtain 
remaining cells. Both populations were pooled, centrifuged at llOO rpm 
(225 g), resuspended in fresh RPM! 1640 with 20% plasma, and cultured 
in 0.2 mJ volumes in flat bottomed microtiter plates (Microtest II tissue 
culture plate, catalog #3040, Falcon Plastics, Oxnard, Calif.) with and 
without the addition of antigens [9]. In the studies presented in ttus 
paper, responding cell concentrations in the second cultures were 
between 4.1-10 x 10" leukocytes/ml (about 10[' cells/well). 
Preparation of DNP·Autologous and DNP·ALLogeneic CeLLs 
On the morning of (first) culture harvest, fresh leukocyte-rich plasma 
was prepared as previously described and diluted with RPMI 1640 and 
HEPES with DNBSO.] to a nnal concentration of 2 x 10" cells/mJ and 
200 J.Lg DNBSO,,/mJ. DNBSO,,-treated and untreated control cells were 
then incubated in a 37°C, 5% CO2 humidified incubator for 1 hr in 50 
mJ conical tubes, after which they were diluted with RPMI 1640 and 
spun down at 1500 rpm X 5 min. The supernatant was removed and 
the cells were resuspended and washed one more time before counting. 
Three different concentrations of stimulator cells were used, as indio 
cated. 
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DNA Synthe.~is Assay 
3H-thymidine-methyl (3HTdR; 17-22 Ci;mmole; 1 mCi;ml; catalog 
no. TRK 120, Amersham/ Searle, Chicago, Ill.), 2 /LCi/well, was added 
for the final 3 hr of incubation. (Harvest was performed at about 44 hr 
after culture initiation.) Samples were harvested with the Multiple 
Automated Sample Harvester (MASH II, Microbiological Associates, 
Bethesda, Md.) and results were expressed as cpm ± SEM of Quadru-
plicate cultures [10). 
St· uI . I d (SI) cpm with DNBSO:!-treated cells 1m atlOn n ex = ------:::-;---:--~-;---;-;--­
cpm with untreated cells 
Histocompatibility Typing 
HLA typing was performed by a microdrop cytotoxicity method 
[11). HLA-DRw typing was performed according to the method de-
RESPONDER H F RESPONDER R C RESPONDER A l RESPONDER T J 
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IDENTITY 
scribed by Mann et al [12). DRw antigens were assigned based on the 
reactivity of alloantisera cytotoxic to B lymphocytes. Antisera used in 
these studies were those that defined DRw specificities based on the 
results of the VII International Histocompatibility Workshop. Typing 
was performed on these randomly selected unrelated volunteers after 
lymphocyte proliferation studies had been completed. 
RESULTS 
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The experiments illustrated in Table I and Fig 1 compare 
restimulation of the DNP-self clonally primed lymphocytes to 
autologous and allogeneic DNBSOa-treated and untreated leu-
kocytes. In Fig 1, the HLA-A and B and DRw antigens and the 
response in total cpm are given for each combination tested in 
a dose response to DNBSOa-treated simulator cells. A pattern 
of response to the DNCB-sensitized primed lymphocytes was 
seen in each experiment. The highest stimulation was observed 
using dinitrophenylated autologous cells (identity) with the 
exception of experiments I b and Sa. Response could be ordered 
in each of the other experiments based on the number of HLA 
and DRw antigens shared with the autologous cells. From these 
data no correlation could be made with sharing of a specific 
HLA-A, B, or DRw antigen. Each of the 2 exceptions is of 
interest. In experiment 1 b, autologous stimulators actually gave 
the best response by the criterion of stimulation index (at the 
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shared by the stimulating allogeneic cells. In experiment Sa, the 
allogeneic stimulators and the responder shared both DRw 
antigens as well as one HLA-B antigen. Lacking family data, it 
is not possible to determine if these increased responses are 
related to haploidentity. Overall, Fig 1 shows that the degree of 
response to unrelated DNP-allogeneic leukocytes varied ac-
cording to the number of HLA antigens shared as measured by 
current serologic typing methods. 
FIG 1. Accelerated response of DNP-self primed responder lympho-
cytes to dinitrophenylated autologous (identity) and allogeneic leuko-
cytes. Each point represents responses measured after 44 hr of culture 
at the indicated concentration of stimulator cells. Notation to the right 
of each line refers to the number of HLA-A, B and DRw antigens 
shared. 
Another interesting finding illustrated in the example shown 
in Table I and Fig 2 is the response of DNP-primed leukocytes 
to unmodified allogeneic as compared to autologous stimula-
tors. Figure 2 illustrates that these responses were not related 
necessarily to differences in DRw antigens. In these experi-
ments, lack of sharing of DRw antigens did not appear to give 
greater stimulation by untreated cells than did a single differ-
ence in DRw or identity of DRw. Thus it appears that cells 
primed with dinitrophenylated autologous leukocytes may re-
spond differently to untreated allogeneic cells than would be 
TABLE 1. Autologous and allogeneic DNP representation to DNP clonally primed lymphocytes" 
(Expt. 3a): Responder RC. x RC.-DNP primed leukocytes 
A 
1,2 
A 
1,32 
A 
3,23 
A 
3 
B 
5.1,15 
B 
40,17 
B 
17,21 
B 
14 
DRw 
1,6 
DRw 
7,4 
DRw 
3,4 
DRw 
2,7 
RC DNBS03 
· . untreated 
TJ DNBSO. 
· . untreated 
PM DNBSOa 
· . untreated 
DC DNBSOa 
· . untreated 
29740 ± 506 
5343 ± 918 
8701 ± 485 
5726 ± 370 
6802 ± 1234 
6319 ± 1405 
3807 ± 611 
5670 ± 440 
5.5 
1.5 
1.1 
0.7 
38367 ± 772 41418 ± 1120 
5642 ± 510 6.8 7313 ± 115 5.7 
17201 ± 1281 18458 ± 6146 
7527 ± 527 2.3 13745 ± 372 1.3 
13651 ± 1014 17199 ± 600 
10531 ± 783 1.3 12282 ± 742 1.4 
6114 ± 724 15473 ± 781 
12967 ± 916 0.5 15938 ± 1051 1.0 
(Expt. 3b): Responder T .J . x T .J.-DNP primed leukocytes 
A B DRw T J DNBSOa 65912 ± 3546 147.1 778773 ± 695 90960 ± 2834 117.5 
1,32 40,17 7,4 .. untreated 448 ± 36 862 ± 122 91.4 774 ± 56 
1~ 5. 1~5 ~~w RC. ~~~~~d ~~~! ~~~ 2.3 2~!:7 6.7 5~~~! i~: 7.8 
A B DRw PM DNBSOa 41226 ± 2906 212 57685 ± 895 63 72538 ± 2429 3.1 
3,23 17,21 3,4 . . untreated 1948 ± 311 . 9222 ± 1770 . 23464 ± 3191 
A B DRw DC DNBS03 805 ± 128 0.4 8796 ± 990 09 29100 ± 1801 1.6 
-3---- 14 2,7 . . untreated 2095 ± 568 9367 ± 859 . 18052 ± 1311 
"RC. and T.J. cells were each primed by culture of 3 x 10" untreated and 1.8 x 106 DNBS03-treated cells/flask in 16% and 17% autologous 
plasma, respectively. After 10 days incubation, each was resuspended in 20% fresh pooled plasma at 5 x 10· / ml. Stimulator cells prepared fresh 
gave a maximum cpm of 2907 ± 867 for RC.-DNBSOa with others yielding 232 to 1612 cpm. RC. responders alone gave 1832 ± 183 cpm and 
15,927 ± 924 with 2.5 mg DNP-aspartic acid. T .J . responders alone gave 297 ± 29 cpm and 43,587 ± 2024 cpm with 2.5 mg DNP-Asp acid. 
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expected if a standard MLR were involved. Unlike the response 
to DNP-allogeneic cells, no correlation could be made between 
the degree of HLA sharing and the magnitude of the primed 
lymphocytes' response to untreated allogeneic cells, indicating 
the possible formation of allogeneic-like neoantigens by dinitro-
phenylation. 
Table II illustrates examples of 2 DNCB-sensitized subjects 
where reciprocal stimulation and responses were available. As 
noted in these examples, the relationship was not always recip-
rocal. Of interest is the fact that the examples showing reason-
able reciprocity by both total cpm and stimulation index were 
2 sharing situations. 
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FIG 2. Accelerated response of DNP-self primed responder lympho-
cytes to unmodified autologous and allogeneic leukocytes. Each point 
represents the response measured after 44 hr of culture at the indicated 
concentration of fresh, untreated stimulator ceUs. Notation to the right 
refers to the number of HLA-DRw antigens shared. 
Expl. DNP-Primed Responder Reciprocal Allogeneic 
Vol. 73, No.3 
DISCUSSION 
Our data indicate that, by criteria of stimulation index and in 
most cases by total cpm to DNBSO~-treated cells, the maximal 
restimulation of DNP-primed lymphocytes was to autologous 
DNBSO~-treated leukocytes (identity). Correlation with degree 
of HLA-sharing occurred to a significant degree, considering 
that the DNCB-sensitive subjects were unrelated and randomly 
selected from a group of adult volunteers including both black 
and caucasian populations. The selection of the responders was, 
however, not completely random since only subjects who gave 
the highest in vitro responsiveness to DNCB were selected as 
responders. In most cases these subjects were also the most 
sensitive in vivo [13). This finding correlates with the histocom-
patibility restriction found to chemically modified leukocytes 
in both proliferative [14] and cytotoxic response [14,15] and 
viral induced cytotoxic response [16] in vitro in mice. These 
and many other similar studies have demonstrated histocom-
patibility restriction in animals. Restriction has generally been 
found to involve a requirement for immunogenetic similarity 
between the initial and restimulating antigen presenting cells 
in the thymus-derived T cell proliferative response [17,18). The 
second culture cytotoxic response to antigen modified human 
leukocytes is restricted to similarly modified autologous leuko-
cytes [19] or those modified cells sharing identity of sero-defined 
HLA loci [20,21]. The relationship to HLA-D related typing is 
most evident where allogeneic dinitrophenylated cells gave a 
greater response than the corresponding autologous cells (Fig 
1, expt 5), corresponding to sharing of both HLA-DRw antigens. 
In this regard it should be noted that primed lymphocyte typing 
can detect reactions other than HLA-D as defined by homozy_ 
gous typing cell methods [22,23). Our data are consistent with 
the observation of Seldin and Rich that there is autologous 
preference in lymphocyte proliferative response to leukocytes 
primed to hapten modified self [24]. Evidence that the self-
specific products determined by MLR and DNP-antigen pre-
senting function are similar comes from studies on the effect of 
UV light which indicate that both functions are sensitive to UV 
light in first culture and relatively though variably resistant in 
primed cultures [1,25]. Detailed dose-response studies on the 
primary MLR and DNP-presenting function demonstrate strik-
ingly similar patterns (unpublished data). 
Our data in this study and elsewhere [4-6] show that leuko-
cytes clonally primed to DNP-self recognize and respond in 
some instances to untreated allogeneic cells to a significant 
degree. It might be postulated that this alloreactivity is the 
result of nonspecifically stimulated lymphocytes remaining 
Stimulator in Second Culture 
Autologous Allogeneic HLA Antigen Shared 
cpm S.l. cpm S.I. 
----
Two Antigens Shared 
-------
H F R C 80697 20.3 39452 6.6 A-2; B-5.1 
R C H F 93921 26.9 111093 9.8 
2 HW E H 95452 57.8 29384 6.2 A-2; DRw-2 
E H H W 78946 31.4 52229 3.2 
----
One Antigen Shared 
:3 R C T J 41418 5.7 18458 1.3 A-I 
T J R C 90960 117.5 58016 7.2 
4 A L T J 62367 31.4 1700 1.2 DRw-7 
T J A L 156144 100.3 39902 1.0 
5 DT T J 103466 4.8 125294 5.6 DRw-7 
T J 0 T 80873 15.4 7364 1.0 
• As in Fig 1 and 2 and Table I. leukocytes were primed for about 10 days with autologous dinitrophenylate? leu~~cytes. The~.ceLls were then 
recultured with either untreated and dinitrophenylated autologous or allogeneic cells for 44 hr and labeled With tritiated thymldme. The results 
are expressed as total cpm and stimulation index (SO after 3 hr label of secondary culture. Stimulator leukocytes are at a concentration of 5 X 
IO"/ml. whereas responders were between .4 and I x 106/mt 
Sept. 1979 
after primary culture. However, data on antigen specificity of 
primed cells [6,9J and the occurrence of such allogeneic cross 
reactivity only in specific instances argue against this. Both 
Janeway et al [26J and Lemonnier et al [27] have demonstrated 
that the converse event occurs in rodent cells with the hapten 
TNP. Janeway et al [26] demonstrated, using BUDR and light 
elimination, that allogeneic primed mouse cells contain a subset 
of killer cells which are cytotoxic to TNP-self. The immune 
equivalence implied by these studies supports our fmding that 
haptenic modification may create new antigenic determinants 
which resemble certain alIoantigens. While the above studies 
deal with self-specific requirements for recognition of haptens, 
we have also demonstrated self-specific requirements for 
solu ble microbial antigens using the clonal priming approach 
[6,9,28,29]. Others have also employed this approach with sol-
uble antigens [30] including primary in vitro sensitization [31]. 
Our fmdings here in conjunction with these studies indicate 
that T -dependent antigen recognition depends on factors which 
are similar to or identical with the histocompatibility factors 
responsible for allogeneic reactivity. These studies on haptens 
and soluble antigens are in keeping with our working hypothesis 
that self-specific factors or immune response gene products are 
operative in all immune responses and lead to a quantitatively 
unique immune response to all antigens in each individual 
[4,5,7,32]. 
Several reports of interest have appeared since this manu-
script was originally submitted. Thorsby and Nousiainen 
(Scand J Immunol 9:183, 1979) and Seldin, Rich and Dupont 
(J Immunol 122:1828, May, 1979) concluded that following in 
vitro priming with TNP that the effect was specifically HLA-D 
as determined by D related B cell serologic typing and homo-
zygous typing cell methodology. While neither of these groups 
saw an effect from serologic A, B or C antigens this might be 
due to a greater effect of the D locus as indicated by our 
previous report of ultraviolet sensitivity in flrst culture. The 
data of Seldon, Rich, and Dupont suggests a possible additive 
effect from the B locus although, as the authors concluded, it 
was not statistically significant. It is possible that with DNP 
and in vivo sensitization we were able to detect an additive 
effect from the A and B loci that would not be apparent with in 
vitro sensitization. 
We would like to thank Dr. Ronald B. Corley for his laboratory 
consultation on optimal conditions for mixed leukocyte culture priming 
and Mary Jane Talley and Joseph C. Cason for technical assistance. 
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